A kind of preparation method of mitiglinide calcium
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 中国人民解放军联勤保障部队第九六六医院
- Publication Date
- 2016-06-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2
Abstract
Description
technical field
[0001] The invention relates to the field of medicine, in particular, the invention relates to a preparation method of mitiglinide calcium. Background technique
[0002] Bis[(2s)-2-benzyl-3-(cis-hexahydroisoindole-2-carbonyl)propanoic acid] monocalcium dihydrate (mitiglinide calcium), molecular formula C 38 h 48 CaN 2 o 6 2H 2 O, the English name is MitiglinideCalciumHydrate, and the structural formula (I) is as follows:
[0003]
[0004] Miglinide Calcium was synthesized by Japan Tachibana Pharmaceutical Co., Ltd. and launched in Japan in April 2004. It is used for type Ⅱ diabetic patients whose hyperglycemia cannot be effectively controlled by diet and exercise therapy. Miglinide calcium is the third meglitide drug after repaglinide and nateglinide, which is a derivative of phenylalanine. Miglinide calcium closes the ATP-dependent K channel on the pancreatic β-cell membrane, causing Ca influx, increasing the intracellular Ca concentration and degra...